1. Home
  2. CRVS vs ZKH Comparison

CRVS vs ZKH Comparison

Compare CRVS & ZKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVS
  • ZKH
  • Stock Information
  • Founded
  • CRVS 2014
  • ZKH 1998
  • Country
  • CRVS United States
  • ZKH China
  • Employees
  • CRVS N/A
  • ZKH N/A
  • Industry
  • CRVS Biotechnology: Pharmaceutical Preparations
  • ZKH
  • Sector
  • CRVS Health Care
  • ZKH
  • Exchange
  • CRVS Nasdaq
  • ZKH Nasdaq
  • Market Cap
  • CRVS 459.0M
  • ZKH 486.5M
  • IPO Year
  • CRVS 2016
  • ZKH 2023
  • Fundamental
  • Price
  • CRVS $8.04
  • ZKH $2.93
  • Analyst Decision
  • CRVS Strong Buy
  • ZKH
  • Analyst Count
  • CRVS 4
  • ZKH 0
  • Target Price
  • CRVS $13.75
  • ZKH N/A
  • AVG Volume (30 Days)
  • CRVS 1.1M
  • ZKH 16.0K
  • Earning Date
  • CRVS 11-04-2025
  • ZKH 11-21-2025
  • Dividend Yield
  • CRVS N/A
  • ZKH N/A
  • EPS Growth
  • CRVS N/A
  • ZKH N/A
  • EPS
  • CRVS N/A
  • ZKH N/A
  • Revenue
  • CRVS N/A
  • ZKH $1,221,845,808.00
  • Revenue This Year
  • CRVS N/A
  • ZKH $5.54
  • Revenue Next Year
  • CRVS N/A
  • ZKH $9.38
  • P/E Ratio
  • CRVS N/A
  • ZKH N/A
  • Revenue Growth
  • CRVS N/A
  • ZKH N/A
  • 52 Week Low
  • CRVS $2.54
  • ZKH $2.50
  • 52 Week High
  • CRVS $10.00
  • ZKH $4.07
  • Technical
  • Relative Strength Index (RSI)
  • CRVS 64.17
  • ZKH 48.68
  • Support Level
  • CRVS $7.46
  • ZKH $2.89
  • Resistance Level
  • CRVS $7.96
  • ZKH $3.03
  • Average True Range (ATR)
  • CRVS 0.56
  • ZKH 0.12
  • MACD
  • CRVS 0.01
  • ZKH 0.00
  • Stochastic Oscillator
  • CRVS 75.46
  • ZKH 50.00

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

About ZKH ZKH Group Limited each representing thirty-five (35)

ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.

Share on Social Networks: